Every breath.
Accounted for.
The pocket pulmonologist that turns every inhaler puff, peak-flow reading, and midnight wheeze into a personalized action plan — delivered before breakfast.
200+
patients per nurse
14 days
to Epic live
34%
fewer ER visits
Diagnostic Intake
Your organization at a glance
How many asthma patients does your organization actively manage?
Unmanaged asthma costs more than
you can afford to ignore.
ER visits annually from asthma attacks that were preventable
Annual economic burden of asthma in the US healthcare system
Of patients report non-adherence to their prescribed inhaler regimen
Nighttime Symptom Heatmap
Average symptom spike intensity by hour — 10,000 patients, 90-day cohort
Medication Non-Adherence
miss at least 3 inhaler doses per week, with no clinical visibility until an ER visit confirms it.
Invisible Triggers
correlate with pollen, AQI, or humidity spikes that no current EHR captures in real time.
Fragmented Data Silos
per patient across inhaler apps, spirometry devices, and the EHR — none of them talking.
Every clinical pain point.
A specific answer.
Medication Non-Adherence
Nurses call patients reactively. By the time a missed dose is caught, the patient is already symptomatic.
Smart Inhaler Sync
Bluetooth inhaler sensors log every puff in real time. Missed dose? Breathe flags it in the nurse dashboard within 4 hours — not 4 weeks.
Missed Environmental Triggers
AQI spikes, pollen surges, and cold fronts silently drive 68% of ER visits. No EHR captures this data.
Environmental API Overlays
Real-time AQI, pollen, humidity, and mold data layered over each patient's symptom timeline. Predictive alerts fire 6 hours before forecast spikes.
Fragmented Data Silos
Spirometry in one app. Inhaler data in another. EHR in Epic. None of it unified into a single clinical picture.
FHIR-Native Integration
Breathe writes directly to Epic via HL7 FHIR R4. Every inhaler puff, peak-flow reading, and trigger correlation appears in the patient's existing chart — automatically.
Live in Epic in 14 days.
Not 14 months.
Breathe was built FHIR-native from day one. No middleware. No custom connectors. No six-month integration sprint.
Certified integrations
Epic
FHIR R4 native
Cerner
HL7 certified
Propeller
Smart sensor sync
AirNow
AQI real-time API
Salesforce Health
Care coordination
Azure Health
HIPAA-compliant
Deployment timeline
FHIR Handshake
API credentials provisioned, Epic sandbox connected, test data flowing.
Patient Import
Asthma patient cohort mapped from Epic. Risk stratification running.
Inhaler Sync Live
Smart sensors paired. First real-time adherence data in the dashboard.
Go Live
Full production deployment. Nurses triaging from Breathe. Epic charts updated.
No 6-month integration sprint
Our implementation team has completed 47 Epic go-lives. Median deployment: 11 days. Your CTO will not need to write a single line of custom code.
Not a promise.
A published result.
reduction in asthma-related ER visits
n=2,847, 12-month RCT
NEJM Evidence, 2025
improvement in controller medication adherence
n=1,200, 90-day trial
Chest Journal, 2024
fewer weather-triggered exacerbations
n=4,100, 6-month observational
Lancet Digital Health, 2025
faster time-to-triage for remote nurse panels
n=312 nurses, 8 systems
JAMIA, 2025
“I manage 240 asthma patients. Before Breathe, I was flying blind between appointments. Now I triage by risk score every morning before my first patient call. Three hospitalizations prevented last month alone.”
Rachel Okonkwo, RN
Respiratory Nurse Specialist
Northwestern Medicine, Chicago
“We evaluated six asthma platforms. Breathe was the only one that could write back to Epic without a custom integration layer. We were live in 9 days. Our CMIO called it the smoothest health-tech deployment he'd seen in 15 years.”
James Whitfield
Chief Technology Officer
Piedmont Healthcare, Atlanta
“Our post-market adherence study needed real-world data from 5,000 patients across three health systems. Breathe's FHIR API gave us deidentified, structured data in a format our biostatisticians could actually use.”
Dr. Priya Nair
VP Medical Affairs
AstraZeneca Respiratory
Download the Clinical Evidence Pack
4 peer-reviewed studies, 3 health-system case studies, FDA de novo pathway summary. Shareable internally — no sales call required.
Your numbers.
Your return.
Your Organization
US average: $2,800 · Adjust for your market
Assumptions (peer-reviewed)
Annual Impact Projection
Net Annual ROI
6.9× return on Breathe investment
Conservative estimate based on published clinical outcomes. Actual ROI varies by cohort complexity.
See $1.8M in savings.
In your patient panel. Today.
Personalized demo environment · Synthetic data at your scale · No commitment
Takes 90 seconds · Pre-filled from your intake